Ignite Creation Date:
2025-12-24 @ 11:31 PM
Ignite Modification Date:
2026-01-18 @ 12:34 AM
Study NCT ID:
NCT02596256
Status:
UNKNOWN
Last Update Posted:
2018-04-17
First Post:
2015-11-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Apatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer (AHEAD-301)
Sponsor:
Chinese PLA General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04
Start Date Type:
None
Primary Completion Date:
2019-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-02
Completion Date Type:
ESTIMATED
First Submit Date:
2015-11-02
First Submit QC Date:
None
Study First Post Date:
2015-11-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-04-13
Last Update Post Date:
2018-04-17
Last Update Post Date Type:
ACTUAL